AstraZeneca PLC's Fiscal Year is From January To December.
The item "Price-To-Cashflow-Ratio" stands at 15.22 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of AstraZeneca PLC's third quarter, the item "Price To Cashflow Ratio" stands at 15.22. This represents a decrease of -7.21 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -27.97 percent compared to the value the year prior.
The 1 year change in percent is -27.97.
The 3 year change in percent is -16.81.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price To Cashflow Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Price To Cashflow Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Price To Cashflow Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Price To Cashflow Ratio | 317,433,206,677.55 |
![]() | Novartis AG - Price To Cashflow Ratio | 255,096,620,580.91 |